Evidence map›Paper›PMID 34867369›Full record

ArticleFrontiers in pharmacology2021

Serious Adverse Events Reporting in Phase III Randomized Clinical Trials of Colorectal Cancer Treatments: A Systematic Analysis.

Yanhong Yao, Zhentao Liu, Hua Zhang, Jian Li, Zhi Peng, Jinyu Yu, Baoshan Cao, Lin Shen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yanhong YaoDepartment of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.
Zhentao LiuDepartment of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.
Hua ZhangResearch Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
Jian LiDepartment of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
Zhi PengDepartment of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
Jinyu YuDepartment of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.
Baoshan CaoDepartment of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing, China.
Lin ShenDepartment of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
Peking University · CNPeking University Cancer Hospital · CNPeking University Third Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

colorectal cancerphase III clinical trialreal worldreported proportionSAEs

Identifiers

PMID34867369
PMCPMC8636814
OpenAlexW3213666367

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.